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Abstract
Listeriolysin-O (LLO) plays a crucial role during infection by Listeria monocytogenes. It
enables escape of bacteria from phagocytic vacuole, which is the basis for its spread to
other cells and tissues. It is not clear how LLO acts at phagosomal membranes to allow bac-
terial escape. The mechanism of action of LLO remains poorly understood, probably due to
unavailability of suitable experimental tools that could monitor LLO membrane disruptive
activity in real time. Here, we used high-speed atomic force microscopy (HS-AFM) featuring
high spatio-temporal resolution on model membranes and optical microscopy on giant uni-
lamellar vesicles (GUVs) to investigate LLO activity. We analyze the assembly kinetics of
toxin oligomers, the prepore-to-pore transition dynamics and the membrane disruption in
real time. We reveal that LLO toxin efficiency and mode of action as a membrane-disrupting
agent varies strongly depending on the membrane cholesterol concentration and the envi-
ronmental pH. We discovered that LLO is able to form arc pores as well as damage lipid
membranes as a lineactant, and this leads to large-scale membrane defects. These results
altogether provide a mechanistic basis of how large-scale membrane disruption leads to
release of Listeria from the phagocytic vacuole in the cellular context.
Author Summary
Listeriolysin-O (LLO) plays a crucial role in Listeria monocytogenes infection by allowing
bacteria to escape from intracellular phagosomes and cells via an unknown molecular
mechanism. We used high-speed atomic force microscopy (HS-AFM) supported with
giant unilamellar vesicles imaging (GUVs) to characterize the interaction and dynamics of
LLO with the lipid membranes at the nano-and micro-scale. We show that LLO efficiency
and mode of action as a membrane-disrupting agent is strongly dependent on membrane
cholesterol content and environmental pH. LLO is able to form arc pores and damage
membranes as a lineactant, which is crucial for the processive membrane disruption. The
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latter mechanism, a previously uncharacterized mode of action for this toxin, is strongly
cholesterol dependent and may provide a novel angle of attack against listeriosis.
Introduction
Listeriolysin-O (LLO) is Listeria monocytogenes powerful molecular weapon in host cell invasion,
which is the first step of the disease listeriosis [1]. Following accidental ingestion of Listeria-con-
taminated food, healthy humans suffer from gastroenteritis, while immunocompromised indi-
viduals are affected in the nervous system and can suffer severe damage. Listeria infection is
treated by antibiotics, but as the development of novel antibiotics is a serious bottleneck, an
improved understanding of LLO action may provide novel angles of attack to fight against this
disease.
LLO is a soluble protein of 56kDa molecular weight that belongs to the cholesterol-depen-
dent cytolysins (CDCs) protein family. CDCs are characterized by the requirement of choles-
terol for their pore forming activity and by the formation of largest known transmembrane
pores that can exceed 40nm in diameter [2, 3]. LLO effectively binds to lipid membranes that
contain high concentrations of cholesterol [4]. Subsequently, LLO monomers oligomerize to
form assemblies and then undergo a major conformation change that allows them to penetrate
the membrane and form pores. LLO is different from other CDCs in that it shows pH-depen-
dent stability, its membrane binding is diminished and its structural integrity weakened at pH
of 7.4 and higher and at temperatures above 30°C [5–7]. This allows LLO to act optimally at
the lower pH within the phagosomes of the infected cells, where Listeria is engulfed after cell
entry. Membrane insertion of LLO oligomers and permeabilization of the Listeria-containing
vacuole enables escape of Listeria from the phagosome into the infected cells and spread to
other tissues [1, 2, 6, 8–11]. Bacterial escape to the cytosol is accompanied by uncoupling of the
pH gradient between the primary phagosome and the cytosol. It was shown that this is caused
by LLO-mediated membrane permeabilization that occurs soon after the entry of bacteria into
the cell [11, 12]. This delays maturation of vacuoles, prevents further acidification and allows
replication of bacteria [11, 13]. Larger membrane lesions of the phagocytic vacuole finally
evolve and allow escape of bacteria to the cytosol of the cell and further spreading to neighbor-
ing cells [11]. The mechanisms of phagocytic membrane disruption by LLO are, however,
unknown and understanding of LLO lipid membrane damaging activity would crucially
improve understanding of this most important step in the Listeria pathogenicity mechanism.
Cholesterol-dependence, endosomolytic pore-formation, and pH-dependence of LLO have
been revealed in the last decades and recent works reported structural details of its monomers
and oligomeric complexes [1, 14–17]. Studies using conventional atomic force microscopy
(AFM) and electron microscopy (EM) depicted CDCs on model membranes [14, 16, 18–20],
yet, the slow image acquisition speed (of one to several minutes) of conventional AFM and sam-
ple fixation in EM prohibited a detailed understanding of the dynamic action of LLO. Here, we
used high-speed atomic force microscopy (HS-AFM) [21, 22], a unique tool for studying the
structure and dynamics of membrane processes [23, 24], and acquired HS-AFMmeasurements
at high spatio-temporal resolution during the entire LLO action cycle from monomer assembly
on the membrane surface, LLO oligomerisation, prepore-to-pore transition and finally to the
processive membrane lysis by assembly of many LLO oligomers and monomers acting at
formed or existing lipid membrane defects. This unique observation was independently con-
firmed by experiments employing giant unilamellar vesilces (GUVs) that show reduction of
number of large GUVs in the presence of LLO and membrane permeabilization to compounds
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much larger than the diameter of previously assumed pore architecture. A comprehensive
description of LLO-induced membrane damage at different membrane cholesterol concentra-
tions and at different environmental pH values provides a mechanistic basis for understanding
Listeria escape from phagolysosomes.
Materials and Methods
Protein preparation
LLO was prepared as described in Podobnik et al [16]. The protein was aliquoted and was
stored in 20mMMES, pH 5.6, 100mMNaCl at a concentration of 17μM. Lysenin was prepared
as described in Munguira et al. [35]
Liposome preparation
All lipids in this study were purchased from Avanti Polar Lipids, and used without further
purification: Cholesterol from ovine wool specified as 98% pure and 1,2-dioleoyl-sn-glycero-
3-ethylphosphocholine (DOPC) specified as 99% pure. Briefly, lyophilized lipids were dis-
solved in organic solution chlorophorm:methanol 3:1 vol:vol to give a final concentration of
3mM. An aliquot was poured in a glass vial and evaporated to dryness with clean nitrogen
flow. The resulting lipid film was kept under reduced pressure overnight to ensure the absence
of organic solvent traces. Then, the lipid film was hydrated with Milli-Q water to give a final
lipid concentration of 500μM, subjecting the vials to 5 cycles of agitation of 1 min, and heating
*70°C, well above the transition temperature of the lipid mixtures studied herein. The
obtained multilamellar vesicles were sonicated for 40 minutes in order to obtain LUVs. After
preparation, LUVs suspensions were stored at*4°C and used during maximal 10 days. During
all the preparation processes, samples were protected from light to avoid unspecific oxidation.
Supported bilayer preparation
Supported Lipid Bilayers (SLBs) were prepared by fusion of Large Unilamellar Vesicles (LUVs)
on the mica support, adapted from [25]. To form the SLBs, 2μL of LUVs were deposited on
1.5mm2 freshly cleaved mica surface, which was glued with epoxy to the quartz sample stage.
After 30–40 minutes incubation in a humid chamber, sample was gently rinsed with milli-Q
water and never let dry.
HS-AFM imaging
High-speed atomic force microscopy movies were acquired using 8 μm-long cantilever with
nominal spring constant k = 0.15N/m and resonance frequency f = 0.6MHz in solution. Both
the cantilever and the rinsed mica surface with incubated bilayer were placed into a 120μL
imaging buffer chamber. HS-AFM was operated in oscillating mode. Small oscillation free and
set point amplitude of about 1nm and 0.9nm, respectively, were used, to achieve minimum tip-
sample interaction. LLO water soluble monomers were added to a final concentration of
500nM after identification of the membrane patches on the mica surface. HS-AFMmeasure-
ments were performed at room temperature. Buffer of 20mMMES, pH5.6, 100mMNaCl,
5mMMgCl2 was used for structural observation of LLO by HS-AFM while dynamic character-
izations were carried out in 20mMMES, pH5.6, 100mMNaCl, 1mM EDTA; as we found that
the presence of divalents significantly slowed or inhibited LLO action probably due to stabilisa-
tion of the lipid bilayer. HS-AFM image and data processing were performed using ImageJ
software with a dedicated Plugins developed for HS-AFM [26]. All further analysis, i.e. histo-
gram distributions were analyzed in Matlab and Origin.
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Electroformation of GUVs
Giant Unilmellar Vesicles (GUVs) were prepared by the electroformation method. Lipid stock
solutions of DOPC/Cholesterol 4:1 mol:mol, DOPC/Cholesterol 9:1 mol:mol, DOPC and
POPC/sphingomyelin 1:1 mol:mol (for imaging lysenin activity) were prepared in chloroform.
Rhodamine DHPE was added as fluorescent probe with the final concentration of 0.5mol%.
20μL of lipid stock solution was placed on the conductive ITO slide and dried under reduced
pressure for 30 minutes. The sucrose solution (290mM sucrose in 1mMMES, pH5.6, for prepa-
ration of DOPC/Cholesterol GUVs and 290mM sucrose, 1mMHEPES, pH7.4 for preparation
of POPC/sphingomyelin GUVs) was added to the dry lipid film in the center of the O-ring and
covered with another conductive ITO slide. Electroformation was carried out inside Nanion
vesicle prep pro, where AC current with an amplitude of 3V and a frequency of 5Hz was
applied across the ITO slides for 3 hours (for preparation of DOPC/Cholesterol GUVs) and for
preparation of POPC/Sphingomyelin GUVs an amplitude decreased from 3V to 1,6V and a
frequency decreased from 5Hz to 1Hz in 5 hours. GUVs were sedimented with the glucose
solution (290mM glucose in 1mMMES, pH5.6 for preparation of DOPC/Cholesterol GUVs
and 290 mM glucose, 1mMHEPES, pH7.4 for preparation of POPC/ sphingomyelin GUVs).
The buffer was then exchanged by gentle pipetting with 20mMMES, pH5.6, 150mMNaCl for
preparation of DOPC/Cholesterol GUVs and with 20mMHEPES, 150mMNaCl, pH7.4 for
preparation of POPC/ sphingomyelin GUVs). All solutions used for electroformation, sedi-
mentation and analysis with proteins were isoosmolar, the solution osmolarity was adjusted
using an osmometer.
Sedimented GUVs were used immediately. They were stored at*4°C and never used after
4 days. During the preparation process and storage the samples were protected from light.
Flow cytometry
The GUV suspension was mixed with LLO, dissolved in buffer (20mMMES, pH 5.6, 150mM
NaCl) to final LLO concentrations of 1, 10, 100 and 500nM. The buffer was used instead of
LLO solution in the negative control sample. Samples were incubated for 30 minutes at room
temperature and then analyzed by flow cytometry. Flow cytometric data acquisition and analy-
sis were performed by the PARTEC CyFlow flow cytometer with a 488nm laser and equipped
with FloMax software. The presence of particles was determined by forward and side scatter
(FSC/SSC) parameters, set at logarithmic gain. Minimum threshold of 70 was set at the FSC
parameter to limit the measurement of the smallest vesicles and micelles. At least 15000 events
were recorded for each sample analysis. Size-calibrated fluorescent beads of 1μm, 3.1μm, and
10μm size were used to determine the appropriate size of vesicles in the sample. Flow Jo soft-
ware was used for the analysis of the results.
Imaging with confocal fluorescence microscopy
For the LLO activity experiments, GUVs suspension was mixed with buffer (20mMMES,
pH5.6, 150mM NaCl) and fluorescent dextrans (FDs) and incubated at room temperature. In
parallel, for the experiments with lysenin, GUVs suspension (POPC: Sphingomyelin 1:1 mol:
mol) was mixed with buffer (20mM HEPES, pH7.4, 150mMNaCl) and fluorescent dextrans
(FDs) and incubated at room temperature. The dextrans were passed across a gel filtration col-
umn to determine homogeneity. Fractions were collected and analyzed for permeability of
GUVs and size with dynamic light scattering. Buffer alone was used instead of LLO or lysenin
solution for negative control. The final concentrations were 500nM for LLO or lysenin and
1mg/ml for FDs of 4, 20, 70, 150, 2000kDa in size. Images were recorded on a Leica TCS SP5
laser-scanning microscope with a 40 × oil-immersion objective (numerical aperture = 1.25).
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FDs were excited at 488nm and fluorescence emission detected from 497 to 534nm. Rhoda-
mine in the GUV membranes was excited at 543nm and fluorescence emission was detected
from 573 to 604nm.
Results
Controlled HS-AFMmovie acquisition at sub-second temporal resolution of LLO assembly on
model membranes allowed analyzing its action in a series of well-defined experimental condi-
tions, notably when the protein was exposed to bilayers containing varying amounts of choles-
terol (along with DOPC) and as a function of environmental pH.
DOPC/Cholesterol model membranes were formed on freshly cleaved mica HS-AFM sup-
ports by incubation of large unilamellar vesicle (LUV) suspension at room temperature (see
Materials and Methods). HS-AFM allowed the direct visualization of bilayer formation from
LUV adsorption to the mica surface (S1 Video). This direct imaging of membrane formation
ascertains ideal placement of the subsequent HS-AFM observation of LLO action.
Structural analysis of LLO oligomers
LLO was added to 500nM final concentration onto the bilayers (DOPC:Cholesterol 4:1 mol:
mol, at pH5.6). In typical HS-AFM image frames, the darkest image areas correspond to the
membrane surface and the arc-shaped brighter structures are the protruding LLO complexes
(Fig 1a). From such images the protrusion height from the membrane of the oligomeric protein
complexes could be analyzed. The highest protruding clusters displayed heights of 11.1±0.5nm
(Peak±FWHM) (Fig 1b, blue), very similar to the height of water-soluble LLO [14], and were
therefore assigned to the prepore state. Later, arc-shaped complexes protruded less, only 7.3
±0.2nm (Peak±FWHM), from the membrane surface, and were consequently assigned to the
pore state (Fig 1b, red), as the height difference suggested the vertical collapse of CDCs accom-
panying membrane insertion [16, 19]. These results are in good agreement with previous
studies characterizing the soluble and membrane structure of LLO with various techniques [6,
14, 16].
Recently the soluble state atomic-level-structure of LLO has been solved [14]. However, lit-
tle is known about the detailed structure of the membrane-embedded protein complex, and
studies diverge on the apparently simple question whether the LLO oligomers formed rings or
incomplete arc-shaped pore structures [1, 2, 14–16, 27–29]. A recent structural model, based
on X-ray crystallography and electron microscopy proposed a ring with about 50nm diameter
composed of 36 LLO monomers [14]. Our HS-AFM data permits to obtain detailed insights
into the characteristics of LLO pore assemblies in a native-like environment (Fig 1a). Interest-
ingly, we never observed ring-shaped LLO assemblies. In contrast, LLO formed arcs indepen-
dent on the protein density. Arcs displayed rather well-conserved structural characteristics
with an average arc-length of 51±6nm (Peak+FWHM) (Fig 1c, blue), and an arc curvature
radius of 31±3nm (Peak±FWHM) (Fig 1c, red). Individual LLO monomers in these arcs had
dimensions of 2.5±0.2nm (Peak±FWHM) times 7.0±0.3nm (Peak±FWHM), along the arc
direction and across the assembly, respectively (Fig 1d), meaning that the average arc is consti-
tuted of about 20 monomers. This implies that the final assemblies, if they would form a ring,
would have a diameter of between 60 and 65nm, larger than earlier estimates [14]. However,
we propose that the LLO assembly should not be regarded in that way, as we have evidence
that membrane-asssociated LLO exist mainly in the arcs. We show (i) that> 95% of all assem-
blies are arc-shaped with rather constant dimensions, (ii) that arc radius analysis indicates a
much larger effective diameter than what was proposed rendering the formation of a closed cir-
cular assembly difficult, (iii) strong evidence for the spatio-temporal separation of assembly
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and membrane insertion (see below) hence hampering further assembly growth once the arc
transforms into the pore-state.
Dynamics of LLO assembly on the membrane
Compared to conventional AFM, HS-AFM provides the possibility to assess dynamics at time-
ranges of biological relevance allowing LLO action to be analyzed in real-time (S2, S3, S4 and
S5 Videos). HS-AFM directly revealed the assembly of LLO into arc-shaped oligomers on the
membrane surface (Fig 2a). We reason that the membrane disturbance of a monomer penetrat-
ing into one membrane leaflet is energetically costly and that bringing several units together
minimizes this energy cost, driving oligomerization. This process occurred on time scales as
short as 10s at 500nM LLO concentration. Once arcs have reached maturity, i.e. assembling
about 20 monomers in an arc of about 50nm length, assembly stalled and further length analy-
sis over 60s revealed length fluctuations of a few nanometers, the size of a single subunit and
within the measurement error (Fig 2b). The formation of complete circular ring-shaped
Fig 1. Structural characterization of LLO assemblies by HS-AFM. a) HS-AFM topography image of LLO
oligomers on a DOPC:Cholesterol 4:1 mol:mol membrane observed in 20mMMES, pH5.6, 100mMNaCl,
5mMMgCl2, with 500nM LLO. The LLO forms arc-shaped assemblies. Inset: LLO arcs imaged at high
resolution (time-averaged over 3 consecutive frames) b) Height histogram distributions of pre-pore (red) and
pore (blue) complexes. The Gaussian fits indicate heights of 11.1±0.5nm (n = 120), and 7.3±0.2nm (n = 160)
for the pre-pore and pore oligomers, respectively. c) The oligomers form assemblies with rather well
preserved arc radius (red) of 31±3nm (n = 120) and arc length (blue) of 51±6nm (n = 120). d) The individual
LLO subunits displayed dimensions of a minor axis along the arc (red) of 2.5±0.2nm (n = 120) and major axis
across the arc (blue) of 7.0±0.3nm (n = 160).
doi:10.1371/journal.ppat.1005597.g001
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complexes from arc-shaped lysteriolysin was never observed. Closest to this, annealing of
neighboring arcs was regularly observed. In this case, arc-shaped oligomers were interlocked to
exhibit a rather ellipsoidal surface contour that did not further evolve as a function of time (Fig
2c). Membrane insertion has only been observed when rather advanced arc assemblies have
been formed, indication that the prepore-to-pore transition needs an advanced state of oligo-
merization and might therefore be cooperative (Fig 2d). Quantitatively, single molecule analy-
sis showed varying residence lifetime of prepore complexes on the membrane of up to minutes,
followed by insertion that is completed within seconds. This more rapid membrane insertion
compared to the residence lifetime of prepores is further evidence for a cooperative conforma-
tional change within the units of the prepore arcs for membrane insertion (Fig 2e). Further oli-
gomerisation of already membrane embedded arc-shaped oligomers with other existing LLO
arcs in the insertion state was never observed. These results show that the oligomerisation and
membrane insertion actions of LLO are spatiotemporally uncoupled. Once LLO is in the mem-
brane, the dynamic destruction of the bilayer could directly be observed: membrane defects
occur inside the arc and grow by lateral propagation of the toxins in the membrane (Fig 2f). It
is notable that the perimeter edged by LLO remaining in the prepore state does not propagate
in membrane disruption (Fig 2f, S5 Video)
Fig 2. Dynamic characterization of LLO assembly and action. Buffer condition: 20mMMES, pH5.6, 100mMNaCl, 1mM EDTA, LLO final concentration
500nM. a) Prepore oligomerization process. b): The oligomerisation rate is about 5nm/s (about 2 subunits/s) until completion of an arc after about 10s,
oligomerisation then stalls. c) Annealing process of neighboring arcs: arc-shaped oligomers interlock to form a final ellipsoid LLO assembly that does not
further evolve. d) Membrane insertion process, i.e. prepore-to-pore transition. e) The pre-pore is stable on the bilayer for 60s and then inserts rapidly and
entirely with about 2nm/s (about 1 subunits/s). f) Following oligomerisation and prepore-to-pore transition, bilayer disruption occurs at about 600nm2/s (see
Figs 3 and 4).
doi:10.1371/journal.ppat.1005597.g002
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Membrane destruction by LLO activity
While the LLO membrane destructive action in dependence of cholesterol has been described
in detail [1, 4, 15, 30, 31], and recent AFM analysis described the LLO assembly structures at
high resolution [17], the morphology and dynamics of LLO action on cholesterol containing
membranes remains unknown. The versatility of HS-AFM to dynamically image bilayers of
various compositions and under varying buffer conditions allows structural description of the
mode of action of LLO in detail. Notably, the influences of cholesterol and pH on LLO action
have been studied, both essential factors during the cell infection process.
LLO activity depends on membrane cholesterol content
As earlier reported, LLO activity is optimized at slightly acidic pH [5, 6]. We therefore carried
out measurements to analyze how varying concentrations of membrane cholesterol influences
LLO action in a buffer at pH5.6, containing 20mMMES, 100mMNaCl and 1mM EDTA.
These measurements were performed by adding LLO to a final concentration of 500nM onto
DOPC/Cholesterol model membranes with varying cholesterol content. Our results demon-
strate a novel dynamic view of LLO membrane activity. Notably, two types of membrane
destruction, either from the inside of the membrane, following membrane insertion, or from
membrane borders could be distinguished. In the first case, the pre-pore to pore transition is
indispensible, while in the second case lineactivity alone is sufficient (S6, S7, S8, S9 Videos).
We conceptualize the lineactant activity as the 2D (two-dimensional) analogue to surfactant
activity in 3D. A lineactant is a line-tension modifying agent that ‘solubilizes’ the 2D
membrane.
At 0mol% cholesterol, S6 Video, the membrane is basically resistant to LLO (Fig 3a, 1st
row). As a function of incubation time with 500nM LLO, no membrane damage is detected,
not even after more than 15 minutes. LLO adsorbes next to the bilayer on the mica and is
unable to adhere or damage the membrane border.
At 10mol% cholesterol, S7 Video, the membrane becomes senistive to LLO (Fig 3a, 2nd
row). However, under these conditions LLO was never observed to form arc-shaped assemblies
on the membrane and/or insert the membrane, yet LLO could act from the membrane edges,
‘solubilizing’ the membrane from the sides as a lineactant. This shows that 10mol% cholesterol
are not enough for oligomerisation and insertion, but is a neccessity for membrane disruption.
After about 20 minutes, only small membrane fragments remained.
At 20mol% cholesterol, S8 Video, LLO oligomerization, arc-formation and prepore-to-pore
transition were observed (Fig 3a, 3rd row). LLO penetrated the membrane rapidly under these
conditions. In addition we noted that LLO subsequently disrupted the membrane both from
within the membrane, where the initial arc-complexes served as nucleation points for further
membrane disruption, and from membrane edges.
At 40mol% cholesterol, S9 Video, LLO activity is further accelerated (Fig 3a, 4th row). Arcs
form rapidly everywhere on the membrane, insert and lyse the bilayer; within about 5 minutes
of LLO action the entire membrane was destroyed.
Beyond morphological aspects of the membrane disruption dynamics, the HS-AFMmovies
allowed numerical analysis of the membrane disruption velocity (Fig 3b). The membrane area
was computationaly analyzed in each image frame and the disruption process plotted as a
function of time. The average velocity could be calculated as roughly 0nm2/s,*300nm2/s,
*600nm2/s, and*1200nm2/s membrane disruption velocity for 0, 10, 20 and 40 mol% mem-
brane cholesterol content, respectively, at constant 500nM LLO concentration. Although mem-
brane disruption is not linear, because the circumference-area-ratio changes as a function of
time-course of LLO-action (and this is particularly important for the conditions in which LLO
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acts mainly from the membrane edges) and the experiment is limited to relatively small obser-
vation areas, a rough linear correlation between LLO membrane disruption efficiency and
membrane cholesterol-content emerges (Fig 3b). Membrane disruption only occurred from
borders or defect edges that were decorated with LLO arcs. These arcs appeared to remain of
constant size during dynamic large-scale membrane defect generation (Fig 3c, S9 Video).
Based on the HS-AFM observations, it cannot be determined whether the retracting lipid mate-
rial during the disruption process was solubized by the protein and released into solution or
moved out of the membrane defect.
LLO activity depends on environmental pH
LLO was shown to act efficiently in very different environments such as the phagolysosomal
membrane, where the pH is low, as well as at the plasma membrane level, where it is exposed
Fig 3. LLO activity depends onmembrane cholesterol content. a) HS-AFM frames of the time-course of LLOmembrane disruption as function of
different membrane cholesterol concentrations: from top to bottom: 0mol%, 10mol%, 20mol%, 40mol% cholesterol. All measurements were carried out in
20mMMES, pH5.6, 100mMNaCl, 1mM EDTA, LLO final concentration 500nM. At 0mol% cholesterol, LLOmonomers only adsorb to mica, and no LLO
membrane disruption is observed. At 10mol% cholesterol, LLO acts frommembrane borders, and no typical oligomer structures are observed on the
membrane. At 20mol% cholesterol, LLO pore formation on the membrane is detected, yet the major membrane disruptive activity occurs from the membrane
border. At 40mol% cholesterol, typical LLO oligomers are formed on the membrane and lead to membrane destruction. b) Normalized membrane disruption
area versus observation lag-time at varying membrane cholesterol content. Quantitatively,*0nm2/s,*300nm2/s,*600nm2/s, and*1200nm2/s membrane
disruption velocity are detected at 0mol% (cyan), 10mol% (red), 20mol% (green), 40mol% (blue) membrane cholesterol concentration, respectively. The
hyphen line is the membrane disruption velocity from oligomer membrane insertion, while the dashed line documents membrane disruption from bilayer
borders. The solid line is the total membrane disruption velocity. c) Detailed illustration of the lateral expansion of arc pores during membrane destruction of a
40mol% cholesterol containing membrane. Destruction only progresses on defect borders decorated by LLO.
doi:10.1371/journal.ppat.1005597.g003
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to the physiological pH [4, 10–12, 20]. To learn more about the pH-dependence of LLO mem-
brane disruption, we designed our next measurements under three typical pH conditions, i.e.
acidic pH5.6, neutral pH7.6, and alkaline pH9.6, on a DOPC:Cholesterol 4:1 mol:mol mem-
brane, knowing that this cholesterol content is typically close to physiological and allows the
toxin to act efficiently [32] (S10 and S11 Videos).
As reported above, at pH5.6 LLO is highly efficient (Fig 4a, 1st row): The entire functional
path is supported under such conditions, notably, LLO undergoes prepore-to-pore transition cre-
ating novel membrane defects and then disrupts the membrane at about*600nm2/s (Fig 4b).
At pH7.6, S10 Video, membrane disruption could also be observed, but only from mem-
brane edges and no well-defined prepore oligomers were observed on the membrane (Fig 4a,
2nd row). Nevertheless, this experiment demonstrated that the inactivation of LLO at neutral
pH was not complete, despite that neutral pH hampered the formation of oligomeric com-
plexes and insertion, the membrane ‘solubilisation’ process still occurred. Importantly, mem-
brane disruptions occurred at the same velocity as at acidic pH,*600nm2/s (Fig 4b).
In contrast, at alkaline pH9.6, S11 Video, LLO was inactive and no membrane disruption
(*0nm2/s) could be detected. Fast LLO diffusion along the membrane surface was detected,
but no membrane attachment, oligomerisation or penetration could be observed, despite the
presence of cholesterol in the membrane (Fig 4a, 3rd row). This finding indicates that LLO at
alkaline pH does neither engage into protein-lipid or protein-protein interactions, probably
due to unfavorable charges exposed on the protein surface, in agreement with earlier work [4].
LLO progressively permeabilizes GUVs for large compounds
The HS-AFM experiments have revealed that LLO can induce large-scale membrane destruc-
tion. In order to prove that these observations on supported lipid bilayers were representative
Fig 4. LLO activity depends on the environmental pH. a) HS-AFM frames comparing LLO activity at different environmental pH on a 20mol% cholesterol
containing bilayer. All measurements were carried out in 20mMMES, 100mMNaCl, 1mM EDTA, LLO final concentration 500nM. At pH5.6 membrane
disruptive activity is efficient from pores and propagating from generated defects and membrane borders. At pH7.6, the membrane is disrupted from its
edges. LLO oligomers formed at membrane borders do not display typical arc-shaped architecture. At alkaline pH 9.6, the efficiency of LLO is abolished. LLO
float on the membrane surface without binding or insertion. b) Normalized membrane disruption area versus observation lag-time. The membrane disruption
velocity is*600 nm2/s,*650nm2/s, and*0nm2/s at pH5.6 (green), pH7.6 (red), and pH9.6 (cyan), respectively. The hyphen line is the membrane
disruption speed from LLO oligomer insertion. The dashed line represents membrane disruption from the bilayer border. The solid line is the total membrane
disruption.
doi:10.1371/journal.ppat.1005597.g004
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for LLO action, GUVs were formed in order to independently confirm LLO membrane
destructive activity. GUVs were prepared by electroformation from DOPC/Cholesterol 4:1
mol:mol lipid mixture (lipid composition used in the HS-AFM experiments) and imaged at
pH5.5. GUVs size distributions were analyzed by flow cytometry in the presence of various
concentrations of LLO. Flow cytometry revealed that presence of LLO caused drastic reduction
in the number of GUVs that were larger than 3μm in diameter (Fig 5a and 5b). At 500nM LLO
concentration (concentration used in HS-AFM experiments) only few GUVs remained in the
mixture (Fig 5b). Confocal microscopy confirmed these results and showed a drastic reduction
in the number of GUVs in the presence of LLO, in addition to GUV permeabilization (Fig 6a–
6c). We have performed several additional control experiments. The population of large GUVs
composed of DOPC alone is not decreased in the presence of LLO, in agreement with the
Fig 5. Effect of LLO on the size of giant unilamellar vesicles (GUVs). a) Flow cytometry analysis of GUVs
destruction by LLO: GUVs in the absence (gray dots) and presence of 500nM LLO (black dots). Size-
calibrated fluorescent beads (orange) are shown for comparison. b) Percentage of GUVs larger than 3μm, on
the right of the gray line in a), were quantified for different LLO concentrations. c) Flow cytometry analysis of
DOPCGUVs in the absence (gray dots) and presence of LLO (black dots). d) Quantification of data
presented in c) performed as in b). e) Flow cytometry analysis of POPC/sphingomyelin 1/1 (mol%) GUVs in
the absence (gray dots) or presence (black dots) of lysenin. f) Quantification of data presented in e performed
as in b. The data from three independent experiments are shown in panels b, d and f. Average ± S.D.
doi:10.1371/journal.ppat.1005597.g005
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known LLO inability to associate with the membranes devoid of cholesterol (Fig 5c and 5d). As
another control we have used pore forming toxin lysenin, which belongs to the aerolysin-like
pore forming toxin family [36]. Lysenin forms stable β-barrel pores formed by 9 subunits with
a pore diameter of approximately 3.5nm, which are significantly smaller than pores of CDCs
[35, 37]. Lysenin does not show lineactant activity on lipid membranes as imaged by HS-AFM
[35, 38]. In agreement with these literature data, the population of large vesicles does not
decrease in number upon addition of comparable lysenin concentration ranges (Fig 5e and 5f).
Fig 6. Permeabilisation of GUVs by LLO and lysenin. a) GUVs in the absence of LLO and in the presence of 1mg/ml FD4 in the outside medium. b) GUVs
(left, red membrane stain) in the presence of 500nM LLO and in the presence of 1mg/ml of FD4 after 60 min incubation (middle). The right panel represents
superimposed image). c) Quantification of GUVs permeabilisation in the presence of 500nM LLO and fluorescent dextrans (FD) of various sizes upon
incubation at different time points. ‘C’ on the x-axis marks, control in the absence of LLO and imaged after 60 min. The data presented in red for FD70 are for
membrane composition, which contains 10 mol% of cholesterol, where LLO cannot form pores effectively. d) GUVs (left, red stain) in the presence of 500nM
lysenin and in the presence of 1mg/ml of FD4 or FD10 after 30 min incubation (middle). The right panel represents superimposed image). e) Quantification of
GUVs permeabilisation in the presence of 500nM lysenin and fluorescent dextrans (FD) of various sizes after 30 min. Only the smallest dextran is permeable
through the lysenin pore of fixed diameter of about 3.5nm.
doi:10.1371/journal.ppat.1005597.g006
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Furthermore, HS-AFM results showed that in the presence of cholesterol LLO arc formation
is rapid and that arcs form pores (Fig 2). Most importantly, HS-AFM evidenced a novel LLO
activity mechanism where membrane inserted LLO has high lineactant efficiency and succes-
sively destroys membrane on large-scale. Functional pore formation was analyzed in the
GUVs system by monitoring uptake of fluorescent dextrans of various sizes. We have added
fluorescent dextrans of various sizes, FDX, where X denotes the size of the dextran in kDa, to
the exterior volume of the GUVs in the presence of LLO and checked for fluorescence equili-
bration at different time points. Dextrans of 4kDa and 20kDa dextran, with estimated diameter
of 2.8nm and 6.6nm, respectively, equilibrated readily at 5 min (Fig 6c, 1st and 2nd panels),
while larger dextrans needed more time for equilibration. Particularly interesting is the 150kDa
dextran, which is approximately 17nm in diameter, which poorly equilibrate initially, but
almost fully after 60 minutes (Fig 6c, 5th panel). This dextran is too large to equilibrate through
arc pores. Finally, the huge FD2000 showed some membrane permeability after 60 minutes
(Fig 6c, 6th panel). We have also used DOPC membranes with 10 mol% of cholesterol. We
show that 70 kDa dextran could only enter these GUVs at much later times (60 min), but not
at 5 min as in the presence of 20 mol% cholesterol or more (Fig 6c, 4th panel, data in red). This
is in agreement with HS-AFM data where at this cholesterol concentrations LLO disrupt mem-
branes primarily by lineactant activity but only rarely pores are formed (Fig 3a).
In order to check whether the observed effects are specific to LLO, we have used lysenin, as
a negative control. As expected lysenin pores allowed passage of FD4 across the membranes,
but not other dextrans, such as FD10 or FD70 (Fig 6d and 6e)[36, 37]. This experiment with a
toxin of fixed pore size illustrates that LLO indeed presents a second functional mechanism
that is qualitatively different from other toxins, namely in its capacity of creating large-scale
membrane damages as a function of time.
These experiments on GUVs altogether confirm the HS-AFM imaging on supported mem-
branes. While the kinetics in these experiments are somewhat slower compared to HS-AFM,
the data further supports the model in which small arc pores initially formed are nucleators for
large-scale membrane lesions by LLO.
Discussion
Here we present a first dynamic analysis of LLO membrane activity at high-spatio-temporal
resolution. A DOPC/Cholesterol model membrane system was used at various cholesterol con-
tent bathing in buffers of various pH. These experimental conditions combined with the capac-
ity of dynamic imaging, allowed us to acquire a detailed understanding of the molecular action
of LLO.
There are four key statements that characterize the function of LLO (Fig 7). First, LLO asso-
ciates to the membrane: preconditions to membrane association are mildly acidic pH and the
presence of at least 20mol% membrane cholesterol. Second, LLO oligomerises: preconditions
for oligomerisation are also mildly acidic pH and at least 20mol% membrane cholesterol. In
contrast to preconceptions and models [14, 16], LLO does not oligomerize in full circles in the
used membrane lipid composition (DOPC/cholesterol). LLO forms arc-shaped assemblies of
about 50nm in length and a curvature radius of about 30nm comprising about 20 subunits.
Third, the prepore-to-pore transition leads to membrane insertion: this process is rapid, and
needs slightly acidic pH, as reported before [1, 4–6, 10, 16]. Its efficiency is favored by choles-
terol-content, maybe because cholesterol intercalates between lipids and hence diminishes
lipid-lipid interactions. In this context it is notable that some CDCs, e.g. ILY, bind protein
receptors, but still need cholesterol for insertion [33]. The prepore-to-pore transition seems to
comprise a cooperative aspect, as insertion of monomers or small oligomers were not observed,
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and as the insertion of arcs was faster than the residence lifetime of the same arcs before the
first subunits inserted. Importantly, the oligomerisation process and the membrane insertion
are uncoupled, as oligomerisation in well defined structures takes only place in the prepore
state. Assemblies inserted into the membrane are sufficient to create membrane defects allow-
ing further membrane disruption. Fourth, membrane disruption takes place: The ‘solubiliza-
tion’ process of the membrane is roughly linear with membrane cholesterol content (a further
indication that cholesterol intercalation between lipids favros LLO action) and scaled at
500nM LLO concentration with about (*300nm2/s) at 10mol% cholesterol. This membrane
lysis can start either from a pore formed by LLO, or from a membrane edge, i.e. membrane
defect, in the experimental system. It is important to note that the ‘solubilization’ process
works already at 10mol% cholesterol and is pH-independent, separating completely the mem-
brane disruption process from the membrane insertion process that is pH-dependent.
We propose that these findings have importance in a physiological context of listeriolysis.
In contrast to other CDCs, LLO is not only designed to make holes into the membrane to
destroy ion or nutrient gradients. One of the major tasks of LLO is to allow escape of a large
bacteria from the intracellular phagocytic vacuole. For this, membrane disruption (‘solubiliza-
tion’) is needed [11–13]. We quantitatively reveal that LLO membrane disruption involves
pore formation into a continuous membrane, and disrupting the membrane from the borders,
i.e. continuing to disrupt membrane from pre-existing damages (Fig 7). While the first necessi-
tates slightly acidic pH, the second is maintained at physiological pH. This is the first experi-
mental distinction of these different modes of action and allows understanding that pH
sensitivity is crucial at the very early stages of LLO action. At an advanced stage, when the pH
in the phagocytic vacuole has leveled with the cytoplasm through ion- and proton-gradient dis-
sipation through small LLO pores, the second mechanism is sufficent for further membrane
disruption and Listeria release. The membrane ‘solubilizing’ action is preserved and well effi-
cient at neutral pH, and therefore, it allows complete disruption of the vacuolar membrane.
Fig 7. Schematic representation of LLOmembrane disruptive action summarizing the presented
results. LLO action depends on membrane cholesterol content and environmental pH. LLO forms arc-
shaped pores and creates large-scale defects as a lineactant for Listeria escape. Soluble LLO is represented
in blue, pre-pore LLO in green, and pore LLO in orange, respectively.
doi:10.1371/journal.ppat.1005597.g007
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This second step is likely enhanced with Listeria phospholipases that were shown to act in con-
certion with LLO. Phospholipases hydrolytic activity on phagosomal lipid membrane may fur-
ther expose hydrophobic parts of the membrane, where LLO could act upon [34, 39]. The
membrane ‘solubilisation’ proceeds through activity of LLO at the membrane exposed sites in
the pore formed by inserted arcs and is mechanistically a lineactant process, as LLO were per-
manently imaged at the processive borders progressing in membrane destruction. Altogether,
experiments presented here provide a solid basis for an understanding of the dynamics of
membrane damage induced by LLO in listeriolysis.
Supporting Information
S1 Video. Supplementary Movie 1 Bilayer Formation. Direct visualization of supported lipid
bilayer formation from LUV adsorption to the mica surface. Movie parameters: Image size:
600nm. Full color scale: 5nm. Image acquisition speed: 1s.
(MOV)
S2 Video. Supplementary Movie 2.1 Prepore Oligomerisation. Direct visualization of the
assembly of LLO into an arc-shaped oligomer complex on the membrane surface. Movie
parameters: Image size: 150nm. Full color scale: 13nm. Image acquisition speed: 1s.
(MOV)
S3 Video. Supplementary Movie 2.2 Prepore Oligomerisation And Annealing. Direct visu-
alization of the formation and annealing process of arc-shaped LLO complexes into an ellipti-
cal ensemble. Movie parameters: Image size: 150nm. Full color scale: 13nm. Image acquisition
speed: 1s.
(MOV)
S4 Video. Supplementary Movie 2.3 Prepore To Pore Transition. Direct visualization of the
prepore-to-pore transition of LLO arc-shaped complexes. Movie parameters: Image size:
150nm. Full color scale: 13nm. Image acquisition speed: 1s.
(MOV)
S5 Video. Supplementary Movie 2.4 Membrane Disruption. Direct visualization of the
dynamics of LLO-mediated bilayer destruction. Movie parameters: Image size: 150nm. Full
color scale: 13nm. Image acquisition speed: 1s.
(MOV)
S6 Video. Supplementary Movie 3.1 pH5.6 0mol%chol. In absence of cholesterol, the mem-
brane is resistant to LLO. No observation of membrane disruption at 0mol% cholesterol con-
tent in buffer at pH5.6 and 500nM LLO concentration. Movie parameters: Image size: 600nm.
Full color scale: 7nm. Image acquisition speed: 3s.
(MOV)
S7 Video. Supplementary Movie 3.2 pH5.6 10mol%chol.Direct visualization of membrane dis-
ruption at 10mol% cholesterol content with 300nm2/s velocity, at pH5.6, LLO concentration
500nM. Movie parameters: Image size: 600nm. Full color scale: 13nm. Image acquisition speed: 3s.
(MOV)
S8 Video. Supplementary Movie 3.3 pH5.6 20mol%chol.Direct visualization of membrane
disruption at 20mol% cholesterol content with 600nm2/s, at pH5.6, LLO concentration 500nM.
Movie parameters: Image size: 600nm. Full color scale: 13nm. Image acquisition speed: 3s.
(MOV)
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S9 Video. Supplementary Movie 3.4 pH5.6 40mol%chol.Direct visualization of membrane dis-
ruption at 40mol% cholesterol content with 1200nm2/s, at pH5.6, LLO concentration 500nM.
Movie parameters: Image size: 600nm. Full color scale: 13nm. Image acquisition speed: 3s.
(MOV)
S10 Video. Supplementary Movie 4.1 pH7.6 20mol%chol. Direct visualization of membrane
disruption at pH7.6 with 600nm2/s, LLO concentration 500nM. Movie parameters: Image size:
600nm. Full color scale: 13nm. Image acquisition speed: 3s.
(MOV)
S11 Video. Supplementary Movie 4.2 pH9.6 20mol%chol. Direct visualization of membrane
disruption at pH9.6 with 600nm2/s, LLO concentration 500nM. Movie parameters: Image size:
600nm. Full color scale: 13nm. Image acquisition speed: 3s.
(MOV)
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